{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:50:57Z","timestamp":1790351457727,"version":"4.1.0"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OTT"],"DOI":"10.2147\/ott.s3971","type":"journal-article","created":{"date-parts":[[2010,9,16]],"date-time":"2010-09-16T02:23:24Z","timestamp":1284603804000},"page":"83","source":"Crossref","is-referenced-by-count":4,"title":["Targeted treatment of imatinib-resistant chronic myeloid leukemia: Focus on dasatinib"],"prefix":"10.2147","author":[{"given":"Charles","family":"Chuah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2009,4]]},"container-title":["OncoTargets and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=4720","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T22:00:15Z","timestamp":1477864815000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/targeted-treatment-of-imatinib-resistant-chronic-myeloid-leukemia-focu-peer-reviewed-article-OTT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/ott.s3971","relation":{},"ISSN":["1178-6930"],"issn-type":[{"value":"1178-6930","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}